- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03265522
Tailored Mediterranean Lifestyle Education in Patients With Mild Cognitive Impairment
The Development and Pilot Testing of Tailored Mediterranean Lifestyle Education to Encourage Behaviour Change in Patients With Mild Cognitive Impairment
Evidence suggests that a Mediterranean diet can have a beneficial effect on brain health. Mild cognitive impairment (MCI) describes problems with brain function such as difficulty with day-to-day memory and concentration. It is at this stage that Mediterranean diet could prove beneficial in terms of prevention.
Previous research by Queens University investigated the opinions of patients with MCI and their care givers to inform the development of Mediterranean diet education material to encourage behaviour change. The study suggested that MCI patients lacked awareness of the link between Mediterranean diet and brain function, although were interested to learn more. Feedback on the developed educational material was positive although there were suggested improvements such as tailoring information to memory loss, a potential staged approach to delivery and adaptations to the material content.
This present study aims to pilot test refined educational material among MCI participants to evaluate the feasibility of encouraging dietary behaviour change among this patient group.
Study Overview
Status
Conditions
Detailed Description
This study aims to evaluate the feasibility of a theory-based, tailored Mediterranean lifestyle education intervention to encourage behaviour change in patients with MCI. The proposed study will be a 6 month RCT with a total of 60 MCI patients who will be randomised to 1 of 3 groups:
- Group 1 will receive the Mediterranean lifestyle education resource on one occasion at baseline
- Group 2 will receive the Mediterranean lifestyle education resource at monthly intervals for 5 months accompanied by telephone feedback from the research dietitian
- Group 3 will receive standard care (control group). Participants will receive the Mediterranean lifestyle education resource after their final 6 month study visit (i.e. delayed intervention).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Belfast, United Kingdom, BT9 7AB
- Belfast Health and Social Care Trust
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria
- Diagnosis of Mild Cognitive Impairment by their physician
- Mediterranean diet score (MDS) less than or equal to 4 (Estruch et al., 2006)
- Willing to make changes to their diet
Exclusion Criteria:
- Diagnosis of dementia
- Patients with visual or English language impairment
- Psychiatric problems
- Significant medical comorbidity
- Body Mass Index (BMI) ≤ 19 and ≥ 40 kg/m2
- Excessive alcohol consumption
- Taking high dose nutritional supplements
- Dietary restrictions/allergies that would substantially limit ability to complete study requirements
- Inability to provide informed consent
- History of, or comorbid condition which may alter performance on cognitive tests e.g. stroke, head injury, Parkinson's disease, learning disability
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Group 1: "ThinkMed" resource at baseline
The "ThinkMed" resource contains an information booklet, recipe books, menu plan cards, shopping list cards and goal setting cards.
Participants will receive this resource on one occasion at baseline (n=20)
|
The "ThinkMed" resource contains an information booklet, recipe books, menu plan cards, shopping list cards and goal setting cards.
Participants will receive this resource on one occasion at baseline.
|
Experimental: Group 2: "ThinkMed" resource (staged)
This group of participants will receive the "ThinkMed" resource at monthly intervals for 5 months accompanied by telephone feedback from the research dietitian (n=20)
|
This group of participants will receive the "ThinkMed" resource at monthly intervals for 5 months accompanied by telephone feedback from the research dietitian
|
Placebo Comparator: Group 3: Standard Care (control) group
Participants will continue with the standard care provided by their physician.
Participants will receive the "ThinkMed" resource after their final 6 month study visit (i.e.
delayed intervention) (n=20)
|
Participants will continue with the standard care provided by their physician.
Participants will receive the "ThinkMed" resource after their final 6 month study visit (i.e.
delayed intervention).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Mediterranean Diet Score (MDS) at 6 months
Time Frame: Baseline, 6 months
|
Mediterranean dietary intake will be measured by a validated questionnaire
|
Baseline, 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Physical Activity
Time Frame: Baseline, 6 months
|
RPAQ-Recent Physical Activity Questionnaire
|
Baseline, 6 months
|
Anthropometric measurements
Time Frame: Baseline, 6 months
|
Weight and height measurements to calculate BMI
|
Baseline, 6 months
|
Muscle Strength
Time Frame: Baseline, 6 months
|
Measured using a grip-strength dynamometer
|
Baseline, 6 months
|
Geriatric Depression Scale
Time Frame: Baseline, 6 months
|
Geriatric Depression Scale Questionnaire
|
Baseline, 6 months
|
Functional Assessment (1)
Time Frame: Baseline, 6 months
|
Measured by the instrumental activities of daily living scale (IADL) by Lawton and Brody (1969) questionnaire
|
Baseline, 6 months
|
Cognitive Assessment
Time Frame: Baseline, 6 months
|
A comprehensive cognitive assessment will be performed, including: global cognition, motor skills, executive function episodic/visual memory, and information processing and sustained attention using a validated neuropsychological test battery (Cantab Cognitive Battery, Cambridge Cognition Ltd.)
|
Baseline, 6 months
|
Barriers to consuming a Mediterranean Diet questionnaire
Time Frame: Baseline, 6 months
|
Dietary behaviour change questionnaire to measure adherence to a Mediterranean diet
|
Baseline, 6 months
|
Blood Sample
Time Frame: Baseline, 6 months
|
A blood sample will be taken from participants to be stored for analysis of biomarkers of MD adherence and biomarkers of neurodegenerative disease risk.
|
Baseline, 6 months
|
Functional Assessment (2)
Time Frame: Baseline, 6 months
|
Measured by the Bristol activities of daily living scale (Bucks et al. 1996) questionnaire
|
Baseline, 6 months
|
4-day Food Diary
Time Frame: Baseline, 6 months
|
A food diary will be completed to assess compliance with a Mediterranean diet
|
Baseline, 6 months
|
Change in Lifestyle questionnaire
Time Frame: Baseline, 6 months
|
A questionnaire to measure change in lifestyle behaviours
|
Baseline, 6 months
|
Dietary Quality of Life questionnaire
Time Frame: Baseline, 6 months
|
A questionnaire to measure dietary quality of life
|
Baseline, 6 months
|
Mediterranean Diet Knowledge questionnaire
Time Frame: Baseline, 6 months
|
A questionnaire to measure participants Mediterranean diet knowledge
|
Baseline, 6 months
|
Rand SF-36 HEALTH SURVEY
Time Frame: Baseline, 6 months
|
A questionnaire to measure participants views and beliefs on health
|
Baseline, 6 months
|
Staging Algorithm Questionnaire
Time Frame: Baseline, 6 months
|
A questionnaire to measure participants readiness to change their diet and lifestyle
|
Baseline, 6 months
|
Mediterranean Diet self-efficacy questionnaire
Time Frame: Baseline, 6 months
|
A questionnaire to measure participants self-efficacy
|
Baseline, 6 months
|
Mediterranean diet tolerance questionnaire
Time Frame: Baseline, 6 months
|
A questionnaire to measure tolerance to a Mediterranean diet
|
Baseline, 6 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Process Evaluation (1) - telephone contact evaluation
Time Frame: up to 3 months post intervention
|
Determination individual participation and engagement with the intervention by reviewing telephone contact log record and telephone checklist evaluation
|
up to 3 months post intervention
|
Process Evaluation (2) - study records
Time Frame: up to 3 months post intervention
|
A review of study records- including attrition rates, reason for dropout
|
up to 3 months post intervention
|
Process Evaluation (3) - structured interviews
Time Frame: up to 3 months post intervention
|
Post intervention structured interviews for participant evaluation of the intervention programme and dietary educational materials
|
up to 3 months post intervention
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Jayne Woodside, PhD, Queens University Belfast
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 16/NI/0105
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mild Cognitive Impairment
-
University of California, San FranciscoNational Institute on Aging (NIA)RecruitingMild Cognitive Impairment | Cognitive Decline | Cognitive Deterioration | Cognitive Impairment, Mild | Cognitive Deficits, MildUnited States
-
BaycrestCentre for Aging and Brain Health InnovationUnknownNeurocognitive Disorders | Cognitive Dysfunction | Mental Disorder | Cognitive Impairment, Mild | Cognitive Disorder | Nonamnestic Mild Cognitive ImpairmentCanada
-
Mackay Memorial HospitalBened Biomedical Co., Ltd.RecruitingMild Cognitive Impairment (MCI)Taiwan
-
Thomas Jefferson UniversityJohns Hopkins University; University of Pennsylvania; National Institute on Aging... and other collaboratorsCompletedMild Cognitive Impairment (MCI)United States
-
Palo Alto Veterans Institute for ResearchU.S. Army Medical Research and Development CommandCompletedAmnestic Mild Cognitive ImpairmentUnited States
-
Assaf-Harofeh Medical CenterNeurim Pharmaceuticals Ltd.UnknownMild Cognitive Impairment (MCI)Israel
-
Xuanwu Hospital, BeijingWuhan University; Beijing Friendship Hospital; First Affiliated Hospital Xi'an... and other collaboratorsRecruitingAmnestic Mild Cognitive ImpairmentChina
-
Immunotec Inc.RecruitingMild Cognitive Impairment (MCI)Canada
-
Jennifer BramenNational Institutes of Health (NIH); National Institute on Aging (NIA)CompletedAmnestic Mild Cognitive ImpairmentUnited States
-
Meir Medical CenterTerminatedMild Cognitive Impairment (MCI)Israel
Clinical Trials on "ThinkMed" resource at baseline
-
Queen's University, BelfastWellcome TrustCompletedSubjective Cognitive ImpairmentUnited Kingdom
-
University Hospital Inselspital, BerneCompletedBreast CancerSwitzerland
-
British Columbia Children's HospitalUnknownLegg-Calvé-Perthes DiseaseCanada
-
University Hospital, LilleCompleted
-
University of California, San FranciscoCentre de Recherche en Sante de Nouna, Burkina FasoNot yet recruitingInfectious Disease | Nutritional Deficiency | Neonatal DeathBurkina Faso
-
University of Illinois at Urbana-ChampaignUniversity of California, San Francisco; Mbarara University of Science and... and other collaboratorsTerminated
-
Brigham and Women's HospitalUnknownParents of Healthy NewbornsUnited States
-
Region Örebro CountyUniversity Hospital, Basel, SwitzerlandCompleted
-
Cardiff UniversityPodiatry Department, Cardiff & Vale University Health Board; School of Health... and other collaboratorsUnknownChronic Kidney DiseaseUnited Kingdom
-
University of MonastirCompletedObstructive Chronic Bronchitis With Acute ExacerbationTunisia